Haemonetics
HAE
$83.46
Share price
-1.67%
Change (1 day)
-1.81%
Change (1 year)
Categories
Haemonetics (HAE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.94 B
According to Haemonetics's latest financial reports the company has $0.94 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Haemonetics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $0.81 B | 9.15% |
| 2022-03-31 | $0.74 B | 2.43% |
| 2021-03-31 | $0.73 B | 24.62% |
| 2020-03-31 | $0.58 B | -12.09% |
| 2019-03-31 | $0.66 B | -11.24% |
| 2018-03-31 | $0.75 B | 1.73% |
| 2017-03-31 | $0.73 B | 2.5% |
| 2016-03-31 | $0.72 B | -12.66% |
| 2015-03-31 | $0.82 B | -1.4% |
| 2014-03-31 | $0.83 B | 8.93% |
| 2013-03-31 | $0.76 B | 4.99% |
| 2012-03-31 | $0.73 B | 6.78% |
| 2011-03-31 | $0.68 B | 15.68% |
| 2010-03-31 | $0.59 B | 9.86% |
| 2009-03-31 | $0.53 B | 9.25% |
| 2008-03-31 | $0.49 B | 3.03% |
| 2007-03-31 | $0.47 B | 8.87% |
| 2006-03-31 | $0.44 B | 24.06% |
| 2005-03-31 | $0.35 B | 26.95% |
| 2004-03-31 | $0.27 B | 25.31% |
| 2003-03-31 | $0.22 B | -5.74% |
| 2002-03-31 | $0.23 B | 9.89% |
| 2001-03-31 | $0.21 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 7,190.64% | 🇺🇸 USA |
 Medtronic MDT | $51.99 B | 5,412.03% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $46.84 B | 4,865.66% | 🇺🇸 USA |
 Baxter BAX | $8.46 B | 797.68% | 🇺🇸 USA |
 Becton Dickinson BDX | $25.33 B | 2,585.52% | 🇺🇸 USA |
 Stryker Corporation SYK | $18.59 B | 1,871.02% | 🇺🇸 USA |
 PerkinElmer
PKI | $8.03 B | 751.65% | 🇺🇸 USA |
 Cerus CERS | $53.44 M | -94.33% | 🇺🇸 USA |